May 5, 2022 01:56 PM EDTUpdated 02:56 PM

Are pharma marketers finally moving away from traditional TV advertising? Yes, but it’s a slow roll

Beth Snyder Bulik

Senior Editor

Pharma marketers are finally starting to diversify the advertising media mix, a new study finds, but don’t count on any abrupt shifts away from tried …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Are pharma marketers finally moving away from traditional TV advertising? Yes, but it’s a slow roll

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Are phar­ma mar­keters fi­nal­ly mov­ing away from tra­di­tion­al TV ad­ver­tis­ing? Yes, but it’s a slow roll

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Are pharma marketers finally moving away from traditional TV advertising? Yes, but it’s a slow roll